Beximco Pharma, a part of the Beximco Group, was recently awarded the prestigious Scrip Award in the category of ‘Best Company in an Emerging Market’; an award that seeks to reward exceptional R&D based pharmaceutical companies of emerging markets. The company’s Chief Operating Officer, Mr. Rabbur Reza, who was present at the 13th Annual Scrip Award ceremony held in London, accepted the award on behalf of the company. With this, the company crossed another key milestone. Beximco Pharma is one of Bangladesh’s largest and most successful businesses. Committed to providing access to affordable drugs, the company has emerged as a generic drug manufacturing giant. The company today contributes towards a major chunk of the country’s medical needs. In addition, the exports of Beximco Pharma are majorly directed towards the Philippines, Europe, and the U.S. This is the first time a Bangladeshi company has received the Scrip Award for operational excellence and robust growth in the ...